Citations (73)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Estelle Watson, Akash Khandelwal, Jan Freijer, John van den Anker, Claudia Lefeber & Mariëlle Eerdekens. (2019) Population pharmacokinetic modeling to facilitate dose selection of tapentadol in the pediatric population. Journal of Pain Research 12, pages 2835-2850.
Read now
Read now
Joseph V. Pergolizzi$suffix/text()$suffix/text(), Jo Ann LeQuang, Robert Taylor$suffix/text()$suffix/text(), Michael H. Ossipov, Daniel Colucci & Robert B. Raffa. (2018) Designing safer analgesics: a focus on μ-opioid receptor pathways. Expert Opinion on Drug Discovery 13:10, pages 965-972.
Read now
Read now
Laura E. Gressler, Drayton A. Hammond & Jacob T. Painter. (2017) Serotonin Syndrome in Tapentadol Literature: Systematic Review of Original Research. Journal of Pain & Palliative Care Pharmacotherapy 31:3-4, pages 228-236.
Read now
Read now
M. Förster, S. Helfert, R. Dierschke, M. Großkopf, P. Hüllemann, T. Keller, R. Baron & A. Binder. (2016) Evaluation of the antihyperalgesic effect of tapentadol in two human evoked pain models – the TapCapMentho pilot trial. Expert Opinion on Pharmacotherapy 17:13, pages 1717-1725.
Read now
Read now
Yeung-Jen Chen, Chao-Ching Chiang, Peng-Ju Huang, Jason Huang, Keith Karcher & Honglan Li. (2015) Tapentadol immediate-release for acute postbunionectomy pain: a phase 3, randomized, double-blind, placebo-controlled, parallel-group study in Taiwan. Current Medical Research and Opinion 31:11, pages 2001-2009.
Read now
Read now
Nebojsa Nick Knezevic, Tatiana Tverdohleb, Ivana Knezevic & Kenneth D Candido. (2015) Unique pharmacology of tapentadol for treating acute and chronic pain. Expert Opinion on Drug Metabolism & Toxicology 11:9, pages 1475-1492.
Read now
Read now
Neil Singla, Rachel Margulis, Kenneth Kostenbader, Yanping Zheng, Thomas Barrett, Michael J. Giuliani, Yin Chen & Jim L. Young. (2015) Randomized, double-blind, placebo-controlled study of the efficacy and safety of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen tablets for acute postoperative pain. The Physician and Sportsmedicine 43:2, pages 126-137.
Read now
Read now
Y. K. Lee, J. S. Ko, H. Y. Rhim, E. J. Lee, K. Karcher, H. Li, D. Shapiro & H. S. Lee. (2014) Acute postoperative pain relief with immediate-release tapentadol: randomized, double-blind, placebo-controlled study conducted in South Korea. Current Medical Research and Opinion 30:12, pages 2561-2570.
Read now
Read now
Johan Raeder. (2014) Opioids in the treatment of postoperative pain: old drugs with new options?. Expert Opinion on Pharmacotherapy 15:4, pages 449-452.
Read now
Read now
Nalini Vadivelu, Yili Huang, Brian Mirante, Michael Jacoby, Ferne R Braveman, Roberta L Hines & Raymond Sinatra. (2013) Patient considerations in the use of tapentadol for moderate to severe pain. Drug, Healthcare and Patient Safety 5, pages 151-159.
Read now
Read now
Craig T Hartrick & Jose Rafael Rodríguez Hernandez. (2012) Tapentadol for pain: a treatment evaluation. Expert Opinion on Pharmacotherapy 13:2, pages 283-286.
Read now
Read now
Nalini Vadivelu, Alexander Timchenko, Yili Huang & Raymond Sinatra. (2011) Tapentadol extended-release for treatment of chronic pain: a review. Journal of Pain Research 4, pages 211-218.
Read now
Read now
Stephen E. Daniels, Ron J. Spivey, Sonia Singla, Michael Golf & Francis J. Clark. (2011) Efficacy and safety of oxycodone HCl/niacin tablets for the treatment of moderate-to-severe postoperative pain following bunionectomy surgery. Current Medical Research and Opinion 27:3, pages 593-603.
Read now
Read now
Robert Buynak, Douglas Y Shapiro, Akiko Okamoto, Ilse Van Hove, Christine Rauschkolb, Achim Steup, Bernd Lange, Claudia Lange & Mila Etropolski. (2010) Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study. Expert Opinion on Pharmacotherapy 11:11, pages 1787-1804.
Read now
Read now
Keith A. Candiotti & Melvin C. Gitlin. (2010) Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?. Current Medical Research and Opinion 26:7, pages 1677-1684.
Read now
Read now
Craig T Hartrick. (2010) Tapentadol immediate-release for acute pain. Expert Review of Neurotherapeutics 10:6, pages 861-869.
Read now
Read now
Craig T Hartrick. (2009) Tapentadol immediate release for the relief of moderate-to-severe acute pain. Expert Opinion on Pharmacotherapy 10:16, pages 2687-2696.
Read now
Read now
Stephen Daniels, Ed Casson, Jens-Ulrich Stegmann, Charles Oh, Akiko Okamoto, Christine Rauschkolb & David Upmalis. (2009) A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain. Current Medical Research and Opinion 25:6, pages 1551-1561.
Read now
Read now
Martin Hale, David Upmalis, Akiko Okamoto, Claudia Lange & Christine Rauschkolb. (2009) Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study. Current Medical Research and Opinion 25:5, pages 1095-1104.
Read now
Read now
Stephen E. Daniels, David Upmalis, Akiko Okamoto, Claudia Lange & Jüergen Häeussler. (2009) A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain. Current Medical Research and Opinion 25:3, pages 765-776.
Read now
Read now
Articles from other publishers (53)
Lorenzo Franco-de la Torre, Eduardo Gómez-Sánchez, Othoniel Hugo Aragon-Martinez, Adriana Hernández-Gómez, Diana Laura Franco-González, Juan Manuel Guzmán-Flores, Angel Josabad Alonso-Castro, Vinicio Granados-Soto & Mario Alberto Isiordia-Espinoza. (2023) Analgesic Efficacy and Safety of Tapentadol Immediate Release in Bunionectomy: A Meta-Analysis. Pharmaceuticals 16:9, pages 1287.
Crossref
Crossref
Marlin Comelon, Johan Raeder, Tomas Drægni, Marit Lieng & Harald Lenz. (2021) Tapentadol versus oxycodone analgesia and side effects after laparoscopic hysterectomy. European Journal of Anaesthesiology 38:9, pages 995-1002.
Crossref
Crossref
V. V. Nikoda. (2021) Tapentadol in acute pain: a review of the results of international studies. Modern Rheumatology Journal 15:4, pages 113-119.
Crossref
Crossref
Esben Bolvig Mark, Jens Brøndum Frøkjær, Tine Maria Hansen, Rasmus Bach Nedergaard & Asbjørn Mohr Drewes. (2021) Although tapentadol and oxycodone both increase colonic volume, tapentadol treatment resulted in softer stools and less constipation: a mechanistic study in healthy volunteers. Scandinavian Journal of Pain 21:2, pages 406-414.
Crossref
Crossref
Torbjørn Rian, Eirik Skogvoll, Janne Hofstad, Lise Høvik, Siri B. Winther, Vigdis Schnell Husby, Jomar Klaksvik, Tarjei Egeberg, Kari Sand, Pål Klepstad & Tina Strømdal Wik. (2021) Tapentadol vs oxycodone for postoperative pain treatment the first 7 days after total knee arthroplasty: a randomized clinical trial. Pain 162:2, pages 396-404.
Crossref
Crossref
Katarzyna Korwin-Kochanowska, Arnaud Potié, Kariem El-Boghdadly, Narinder Rawal, Girish Joshi & Eric Albrecht. (2020) PROSPECT guideline for hallux valgus repair surgery: a systematic review and procedure‐specific postoperative pain management recommendations. Regional Anesthesia & Pain Medicine 45:9, pages 702-708.
Crossref
Crossref
Matthew Scott, Alex H. Konstantatos, Thuy Bui, Peter Carne, Rory O'Donohoe, Stephanie Dearaugo & Sarah Donovan. (2020) Acute colonic pseudo‐obstruction leading to perforation: a case‐control study investigating associations to tapentadol. Journal of Pharmacy Practice and Research 50:3, pages 226-232.
Crossref
Crossref
Xinyi Wang, Sujita W. Narayan, Jonathan Penm & Asad E. Patanwala. (2020) Efficacy and Safety of Tapentadol Immediate Release for Acute Pain. The Clinical Journal of Pain 36:5, pages 399-409.
Crossref
Crossref
Christopher Ll. Morgan, Sara Jenkins-Jones, Craig Currie & Garth Baxter. (2019) Outcomes Associated with Treatment of Chronic Pain with Tapentadol Compared with Morphine and Oxycodone: A UK Primary Care Observational Study. Advances in Therapy 36:6, pages 1412-1425.
Crossref
Crossref
Robert B. Raffa, Christian Elling & Thomas M. Tzschentke. (2018) Does ‘Strong Analgesic’ Equal ‘Strong Opioid’? Tapentadol and the Concept of ‘µ-Load’. Advances in Therapy 35:10, pages 1471-1484.
Crossref
Crossref
Jarosław Woroń. (2018) Opioid analgesics in the pharmacotherapy of pain, when in practice it is worth choosing tapentadol. BÓL 19:1, pages 51-53.
Crossref
Crossref
R. B. Raffa, J. V. Pergolizzi, R. Taylor & M. H. Ossipov. (2018) Nature's first “atypical opioids”: Kratom and mitragynines. Journal of Clinical Pharmacy and Therapeutics 43:3, pages 437-441.
Crossref
Crossref
Gertrud Haeseler, Dirk Schaefers, Natalie Prison, Jörg Ahrens, Xiaofei Liu & Annika Karch. (2017) Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone. BMC Anesthesiology 17:1.
Crossref
Crossref
Neil K. Singla, Diana S. Meske & Paul J. Desjardins. (2017) Exploring the Interplay between Rescue Drugs, Data Imputation, and Study Outcomes: Conceptual Review and Qualitative Analysis of an Acute Pain Data Set. Pain and Therapy 6:2, pages 165-175.
Crossref
Crossref
Jessica M. Kohring & Nathan G. Orgain. (2017) Multimodal Analgesia in Foot and Ankle Surgery. Orthopedic Clinics of North America 48:4, pages 495-505.
Crossref
Crossref
Joseph V PergolizziJrJr, Frank Breve, Robert TaylorJrJr, Robert B Raffa, Stephani E Strasburger & Jo Ann LeQuang. (2017) Considering tapentadol as a first-line analgesic: 14 questions. Pain Management 7:4, pages 331-339.
Crossref
Crossref
Nalini Vadivelu, Daniel Chang, Erik M. Helander, Gregory J. Bordelon, Alice Kai, Alan D. Kaye, Dora Hsu, Daniel Bang & Inderjeet Julka. (2017) Ketorolac, Oxymorphone, Tapentadol, and Tramadol. Anesthesiology Clinics 35:2, pages e1-e20.
Crossref
Crossref
Jing-Ping Xiao, Ai-Ling Li, Bi-Min Feng, Yun Ye & Guo-Jun Wang. (2017) Efficacy and Safety of Tapentadol Immediate Release Assessment in Treatment of Moderate to Severe Pain: A Systematic Review and Meta-Analysis. Pain Medicine 18:1, pages 14-24.
Crossref
Crossref
Richard M Langford, Roger Knaggs, Paul Farquhar-Smith & Anthony H Dickenson. (2016) Is tapentadol different from classical opioids? A review of the evidence. British Journal of Pain 10:4, pages 217-221.
Crossref
Crossref
Thomas BarrettKenneth KostenbaderSrinivas NalamachuMichael GiulianiJim L. Young. (2015) Safety and Tolerability of Biphasic Immediate‐Release/Extended‐Release Oxycodone/Acetaminophen Tablets: Analysis of 11 Clinical Trials. Pain Practice 16:7, pages 856-868.
Crossref
Crossref
David Prichard, Christine Norton & Adil E Bharucha. (2016) Management of opioid-induced constipation. British Journal of Nursing 25:10, pages S4-S11.
Crossref
Crossref
Markus Hinder & Alexander Schuhmacher. 2016. Value Creation in the Pharmaceutical Industry. Value Creation in the Pharmaceutical Industry
202
223
.
Neil Singla, Matthew Hunsinger, Phoebe D. Chang, Michael P. McDermott, Amit K. Chowdhry, Paul J. Desjardins, Dennis C. Turk & Robert H. Dworkin. (2015) Assay Sensitivity of Pain Intensity Versus Pain Relief in Acute Pain Clinical Trials: ACTTION Systematic Review and Meta-Analysis. The Journal of Pain 16:8, pages 683-691.
Crossref
Crossref
Jia Wang, George T. Liu, Helen G. Mayo & Girish P. Joshi. (2015) Pain Management for Elective Foot and Ankle Surgery: A Systematic Review of Randomized Controlled Trials. The Journal of Foot and Ankle Surgery 54:4, pages 625-635.
Crossref
Crossref
David Prichard & Adil Bharucha. (2015) Management of opioid-induced constipation for people in palliative care. International Journal of Palliative Nursing 21:6, pages 272-280.
Crossref
Crossref
R.-D. Treede & M. Zenz. (2014) Langzeitanwendung von Opioiden bei chronischen nicht tumorbedingten Schmerzen (LONTS 2)Long-term application of opioids in chronic noncancer pain (LONTS 2). Der Schmerz 29:1, pages 5-7.
Crossref
Crossref
M. Pariser & C. Clarke. 2014. Anesthesia and Perioperative Care of the High-Risk Patient. Anesthesia and Perioperative Care of the High-Risk Patient
191
213
.
A. Cowan, R.B. Raffa, C.S. Tallarida, R.J. Tallarida, T. Christoph, W. Schröder & T.M. Tzschentke. (2014) Lack of synergistic interaction between the two mechanisms of action of tapentadol in gastrointestinal transit. European Journal of Pain 18:8, pages 1148-1156.
Crossref
Crossref
Neil K. Singla, Paul J. Desjardins & Phoebe D. Chang. (2014) A comparison of the clinical and experimental characteristics of four acute surgical pain models: Dental extraction, bunionectomy, joint replacement, and soft tissue surgery. Pain 155:3, pages 441-456.
Crossref
Crossref
Edward Michna, Wendy Y. Cheng, Caroline Korves, Howard Birnbaum, Ryan Andrews, Zhou Zhou, Ashish V. Joshi, David Schaaf, Jack Mardekian & Mei Sheng. (2014) Systematic Literature Review and Meta-Analysis of the Efficacy and Safety of Prescription Opioids, Including Abuse-Deterrent Formulations, in Non-Cancer Pain Management. Pain Medicine 15:1, pages 79-92.
Crossref
Crossref
Mana SaraghiElliot V. Hersh. (2013) Three Newly Approved Analgesics: An Update. Anesthesia Progress 60:4, pages 178-187.
Crossref
Crossref
Winghan J. Kwong, Geoffrey Hammond, David Upmalis, Akiko Okamoto, Min Yang & Shane Kavanagh. (2013) Bowel Function After Tapentadol and Oxycodone Immediate Release (IR) Treatment in Patients With Low Back or Osteoarthritis Pain. The Clinical Journal of Pain 29:8, pages 664-672.
Crossref
Crossref
Gary J VorsangerJean Farrell, Jim Xiang, Wing Chow, Bruce L Moskovitz & Norman R Rosenthal. (2013) Tapentadol, oxycodone or placebo for acute pain of vertebral compression fractures: a randomized Phase IIIb study. Pain Management 3:2, pages 109-118.
Crossref
Crossref
Xu Steven Xu, Mila Etropolski, David Upmalis, Akiko Okamoto, Rachel Lin & Partha Nandy. (2012) Pharmacokinetic and Pharmacodynamic Modeling of Opioid-Induced Gastrointestinal Side Effects in Patients Receiving Tapentadol IR and Oxycodone IR. Pharmaceutical Research 29:9, pages 2555-2564.
Crossref
Crossref
M. Giorgi, A. Meizler & P.C. Mills. (2012) Quantification of tapentadol in canine plasma by HPLC with spectrofluorimetric detection: Development and validation of a new methodology. Journal of Pharmaceutical and Biomedical Analysis 67-68, pages 148-153.
Crossref
Crossref
I. D. Jeong, M. Camilleri, A. Shin, J. Iturrino, A. Boldingh, I. Busciglio, D. Burton, M. Ryks, D. Rhoten & A. R. Zinsmeister. (2012) A randomised, placebo‐controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans. Alimentary Pharmacology & Therapeutics 35:9, pages 1088-1096.
Crossref
Crossref
. (2012) Clinical Efficacy and Safety of Tapentadol Immediate Release in the Postoperative Setting. Journal of the American Podiatric Medical Association 102:2, pages 139-148.
Crossref
Crossref
&NA;. (2011) Tapentadol immediate- and extended-release: a guide to its use in acute and chronic pain. Drugs & Therapy Perspectives 27:12, pages 1-6.
Crossref
Crossref
Chris Pasero. (2011) Tapentadol for Multimodal Pain Management. Journal of PeriAnesthesia Nursing 26:5, pages 343-346.
Crossref
Crossref
Mario Andrés Leotau Rodríguez. (2011) Tapentadol, una nueva opción terapéutica. Revista Colombiana de Anestesiología 39:3, pages 375-385.
Crossref
Crossref
I. Power. (2011) An update on analgesics. British Journal of Anaesthesia 107:1, pages 19-24.
Crossref
Crossref
Craig T. Hartrick & Richard J. Rozek. (2011) Tapentadol in Pain Management. CNS Drugs 25:5, pages 359-370.
Crossref
Crossref
Mila Etropolski, Kathleen Kelly, Akiko Okamoto & Christine Rauschkolb. (2011) Comparable efficacy and superior gastrointestinal tolerability (nausea, vomiting, constipation) of tapentadol compared with oxycodone hydrochloride. Advances in Therapy 28:5, pages 401-417.
Crossref
Crossref
Michele L Matthews & Richard Lufkin. (2011) Tapentadol: A Novel, Centrally Acting Analgesic for Moderate-to-Severe Acute Pain. Journal of Pharmacy Technology 27:1, pages 27-34.
Crossref
Crossref
Vaughn E. Nossaman, Usha Ramadhyani, Philip J. Kadowitz & Bobby D. Nossaman. (2010) Advances in Perioperative Pain Management: Use of Medications with Dual Analgesic Mechanisms, Tramadol & Tapentadol. Anesthesiology Clinics 28:4, pages 647-666.
Crossref
Crossref
Xu Steven Xu, Johan W. Smit, Rachel Lin, Kim Stuyckens, Rolf Terlinden & Partha Nandy. (2010) Population Pharmacokinetics of Tapentadol Immediate Release (IR) in Healthy Subjects and Patients with Moderate or Severe Pain. Clinical Pharmacokinetics 49:10, pages 671-682.
Crossref
Crossref
James E. Frampton. (2010) Tapentadol Immediate Release. Drugs 70:13, pages 1719-1743.
Crossref
Crossref
Bart Morlion, Joseph V. PergolizziJrJr & Robert B. Raffa. (2010) European perspectives on upcoming analgesics: What do they have that we don't—and what do they think about them?. Techniques in Regional Anesthesia and Pain Management 14:2, pages 86-98.
Crossref
Crossref
Giustino Varrassi, Franco Marinangeli, Alba Piroli, Stefano Coaccioli & Antonella Paladini. (2010) Strong analgesics: Working towards an optimal balance between efficacy and side effects. European Journal of Pain 14:4, pages 340-342.
Crossref
Crossref
Clifford Gevirtz. (2010) A Comparative Analysis of Tapentadol, Tramadol, and the Opiates. Topics in Pain Management 25:8, pages 1-7.
Crossref
Crossref
Johan W Smit, Charles Oh, Jens Rengelshausen, Rolf Terlinden, Paulien G. M Ravenstijn, Shean-Sheng Wang, David Upmalis & Bernhard Mangold. (2010) Effects of Acetaminophen, Naproxen, and Acetylsalicylic Acid on Tapentadol Pharmacokinetics: Results of Two Randomized, Open-Label, Crossover, Drug-Drug Interaction Studies. Pharmacotherapy 30:1, pages 25-34.
Crossref
Crossref
William E. Wade & William J. Spruill. (2009) Tapentadol hydrochloride: A centrally acting oral analgesic. Clinical Therapeutics 31:12, pages 2804-2818.
Crossref
Crossref
Craig Hartrick, Ilse Van Hove, Jens-Ulrich Stegmann, Charles Oh & David Upmalis. (2009) Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A 10-day, phase III, randomized, double-blind, active- and placebo-controlled study. Clinical Therapeutics 31:2, pages 260-271.
Crossref
Crossref